Cassie Wetzel

Cassie Wetzel

Associate

Cassie Wetzel is an associate in the Boulder office of Wilson Sonsini Goodrich & Rosati, where she practices corporate and securities law. She advises clients on corporate formation and operation, corporate governance matters, venture capital financings, and mergers and acquisitions. Her experience also includes public company disclosure and securities offerings.

Experience

Education

J.D., University of San Diego School of Law, 2017
Magna Cum Laude, Order of the Coif
B.A., Political Science, University of San Diego
Cum Laude, Minors in Communications and Law & Ethics

Admissions

State Bar of California
State Bar of Colorado

Credentials

Education

J.D., University of San Diego School of Law, 2017
Magna Cum Laude, Order of the Coif
B.A., Political Science, University of San Diego
Cum Laude, Minors in Communications and Law & Ethics

Admissions

State Bar of California
State Bar of Colorado

Select Representations

Advised biotech company ARCA biopharma on the private financing of approximately $275 million in connection with the merger agreement with Oruka Therapeutics
Represented software company Alteryx in $4.4 billion take-private deal with Clearlake and Insight Partners
Advised Amogy, a pioneer of emission-free, energy-dense ammonia power solutions, on $46 million financing
Advised Amerigen Pharmaceuticals on $52.5 million acquisition by ANI Pharmaceuticals
Represented Zovio on its acquisition of TutorMe, an online tutoring solution

Matters

Select Representations

Advised biotech company ARCA biopharma on the private financing of approximately $275 million in connection with the merger agreement with Oruka Therapeutics
Represented software company Alteryx in $4.4 billion take-private deal with Clearlake and Insight Partners
Advised Amogy, a pioneer of emission-free, energy-dense ammonia power solutions, on $46 million financing
Advised Amerigen Pharmaceuticals on $52.5 million acquisition by ANI Pharmaceuticals
Represented Zovio on its acquisition of TutorMe, an online tutoring solution

Recent Insights

Client Highlights

On August 22, 2024, Borealis Biosciences (Borealis), a next-generation RNA medicines company, emerged from stealth with $150 million in combined Series A financing from founding investor Versant Ventures and Novartis AG, as well as committed strategic research collaboration funding from Novartis. Wilson Sonsini Goodrich & Rosati advised Borealis on the transaction.

Learn More

Client Highlights

On June 27, 2024, Nokia and Infinera, a global supplier of innovative open optical networking solutions and advanced optical semiconductors, announced a definitive agreement under which Nokia will acquire Infinera in a transaction valuing the company at $6.65 per share or an enterprise value of US$2.3 billion. At least 70 percent of the consideration will be paid in cash and Infinera’s shareholders can elect to receive up to 30 percent of the aggregate consideration in the form of Nokia ADSs. Wilson Sonsini Goodrich & Rosati advised Infinera on the transaction.

Learn More